Raquel Duarte
Researcher Next ID · RN-040897
Researcher · Medicine
Porto, Portugal
- Works count
- 501
- Citation count
- 10,385
- H-index
- 43
- i10-index
- 164
Research interests
Publications
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine · 2024 · 10.1164/rccm.202410-2096st
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
Pulmonology · 2021 · 10.1016/j.pulmoe.2020.12.012
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
European Respiratory Journal · 2021 · 10.1183/13993003.01786-2021
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
The International Journal of Tuberculosis and Lung Disease · 2021 · 10.5588/ijtld.21.0425
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
International Journal of Infectious Diseases · 2020 · 10.1016/j.ijid.2020.01.042
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
European Respiratory Journal · 2019 · 10.1183/13993003.01522-2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine · 2019 · 10.1164/rccm.201909-1874st
Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs
Jornal Brasileiro de Pneumologia · 2018 · 10.1590/s1806-37562017000000443
New drugs and perspectives for new anti-tuberculosis regimens ☆
Pulmonology · 2018 · 10.1016/j.rppnen.2017.10.009
Point of care diagnostics for tuberculosis
Pulmonology · 2018 · 10.1016/j.rppnen.2017.12.002
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
European Respiratory Journal · 2017 · 10.1183/13993003.00387-2017
Tuberculosis, social determinants and co-morbidities (including HIV)
Pulmonology · 2017 · 10.1016/j.rppnen.2017.11.003
Towards tuberculosis elimination: an action framework for low-incidence countries
European Respiratory Journal · 2015 · https://doi.org/10.1183/09031936.00214014
Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study
American Journal of Respiratory and Critical Care Medicine · 2014 · 10.1164/rccm.201405-0967oc
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
European Respiratory Journal · 2014 · 10.1183/09031936.00188313
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
European Respiratory Journal · 2010 · 10.1183/09031936.00028510
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis ? A TBNET consensus statement
European Respiratory Journal · 2009 · 10.1183/09031936.00120908
Current projects
No projects listed.